Constrained hypermutation and absence of TERT promoter mutations in Lynch syndrome-associated urothelial cancer

Related articles

1. A germline KDM3C polymorphism impairs DNA repair and sensitizes to chemoradiotherapy

   This article has 26 authors:

   1. Adria Hasan
   2. Elena V. Demidova
   3. Pragya Priyadarshini
   4. Philip Czyzewicz
   5. Leonny Gathuka
   6. Takahiko Murayama
   7. Yan Zhou
   8. Zachary AC Kiss
   9. Raksha KR Shastry
   10. Mark Andrake
   11. Gavin Hearne
   12. Karthik Devarajan
   13. Chao Wu
   14. Anshul Shah
   15. Bryant M. Schultz
   16. Denise C. Connolly
   17. Gail L. Rosen
   18. Israel Cañadas
   19. Jeffrey C. Liu
   20. Barbara A. Burtness
   21. J Joshua Smith
   22. Roland L. Dunbrack
   23. Erica A. Golemis
   24. Johnathan R. Whetstine
   25. Joshua E. Meyer
   26. Sanjeevani Arora

2. Intense TP53 pathway selection drives clonal evolution from bone marrow failure to leukemia in ERCC6L2 disease

   This article has 16 authors:

   1. Suvi P.M. Douglas
   2. Ilse Kaaja
   3. Ina I Ikonen
   4. Laura Langohr
   5. Jessica Koski
   6. Marja Hakkarainen
   7. Lotta Katainen
   8. Gisela Barbany
   9. Eva Hellstrom-Lindberg
   10. Kirsi Jahnukainen
   11. Sakari Kakko
   12. Timo Siitonen
   13. Riitta Niinimaki
   14. Esa Pitkanen
   15. Ulla Wartiovaara-Kautto
   16. Outi Kilpivaara

3. Evaluation of Urinary Circulating Tumor DNA to Detect Minimal Residual Disease in Patients with High-Risk Non-Muscle Invasive Bladder Cancer

   This article has 24 authors:

   1. Roger Li
   2. Joshua Linscott
   3. Prithvi Murthy
   4. Kyle Rose
   5. Young Pak
   6. Frank Zhang
   7. Yong Huang
   8. G. Daniel Grass
   9. Jonathan Chatzkel
   10. Noah M. Hahn
   11. David J. McConkey
   12. Joshua J. Meeks
   13. Siamak Daneshmand
   14. Thomas W. Flaig
   15. Seth P. Lerner
   16. Logan Zemp
   17. Michael A. Poch
   18. Philippe E. Spiess
   19. Wade J. Sexton
   20. Scott M. Gilbert
   21. Hongzhi Xu
   22. Pan Du
   23. Shidong Jia
   24. Xuefeng Wang